نتائج البحث - James Geib

  • يعرض 1 - 2 نتائج من 2
تنقيح النتائج
  1. 1
    Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease

    Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease حسب Santosh L. Saraf, Robert Hagar, Modupe Idowu, Ifeyinwa Osunkwo, Kimberly Cruz, Frans A. Kuypers, R. Clark Brown, James Geib, Maria Ribadeneira, Patricia Schroeder, Eric Wu, Sanjeev Forsyth, Patrick Kelly, Theodosia A. Kalfa, Marilyn J. Telen

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy

    Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy حسب Nezam H. Afdhal, Geoffrey Dusheiko, Edoardo G. Giannini, Pei‐Jer Chen, Kwang‐Hyub Han, Aftab Mohsin, M. Rodríguez‐Torres, Sorin Rugină, И. Г. Бакулин, Eric Lawitz, Mitchell L. Shiffman, Ghias-Un-Nabi Tayyab, Fred Poordad, Yasser Mostafa Kamel, Andrés Brainsky, James Geib, Sandra Y. Vasey, Rita Patwardhan, Fiona Campbell, Dickens Theodore

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: